Duell and colleagues (112) observed that carriers of this XRCC1 polymorphism who were smokers, had significantly higher risk of developing PDA than other members in the cohort of 309 PDA patients and 964 control individuals. This evidence concerns the gene XRCC1 and Patent ductus arteriosus.